Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer

Download All
Get up to date with international insights on assessing and targeting BRCA1/2 and other DNA damage repair gene alterations in pancreatic cancer with downloadable slides and on-demand Webcast from a live Webinar plus an expert commentary.
Dirk Arnold, MD, PhD
Michael J. Pishvaian, MD, PhD

On-Demand Webcast

Downloadable Slidesets

Download this slideset to review the latest data on molecular testing considerations for patients with pancreatic cancer.

Michael J. Pishvaian, MD, PhD Released: September 21, 2020

Download this slideset to review the latest data on treating patients with pancreatic cancer and BRCA mutations or other actionable alterations.

Dirk Arnold, MD, PhD Released: September 21, 2020

ClinicalThought

Now that olaparib is approved in the EU, how will your treatment of patients with pancreatic cancer change?

Dirk Arnold, MD, PhD Released: October 30, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings